You are here:

  1. Home
  2. NICE Guidance
  3. Published Guidance

Teduglutide for treating short bowel syndrome

  • Technology appraisal guidance
  • Reference number: TA804
  • Published:  30 June 2022
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Final draft guidance
  2. Draft guidance
  3. Invitation to participate
  4. Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 1

History

Documents created during the development process.

Final draft guidance

  • Final draft guidance

  • Final appraisal document (PDF 308 KB)

    Published:
    01 June 2022
  • Committee papers (PDF 1 MB)

    Published:
    01 June 2022
  • Public committee slides (PDF 317 KB)

    Published:
    01 June 2022

Draft guidance

  • Draft guidance

  • Appraisal consultation document (PDF version) (PDF 350 KB)

    Published:
    11 March 2022
  • Appraisal consultation document (online commenting)

  • Committee papers (PDF 3.96 MB)

    Published:
    11 March 2022
  • Public committee slides (PDF 1.08 MB)

    Published:
    11 March 2022

Invitation to participate

  • Draft scope and provisional stakeholder list comments table (post-referral) (PDF 243 KB)

    Published:
    15 June 2021
  • Final scope (PDF 156 KB)

    Published:
    15 June 2021
  • Equality impact assessment (Scoping) (PDF 121 KB)

    Published:
    15 June 2021
  • Final stakeholder list (PDF 205 KB)

    Published:
    15 June 2021

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 1

  • Draft scope post referral (MSWord 63 KB)

    Published:
    19 April 2021
  • Draft matrix of consultees and commentators post referral (MSWord 73 KB)

    Published:
    19 April 2021
Back to top